Frequently Asked Questions

Your Questions, Expertly Answered

Get clear, professional answers to common questions about cancer treatment, diagnosis, and care from our experienced medical team.

10,000+

International Patients

40+

Countries Served

40yr+

Years of Expertise

40yr+

Years of Expertise
Book a Free Consultation

24/7

Support Available

13+

Value-Added Services

20+

Global Offices
PATIENT GUIDANCE

GET ANSWERS ABOUT YOUR CANCER CARE

Expert insights on what to expect, how to prepare, and how to support your recovery—covering diagnosis, treatment, and beyond.

My mother was diagnosed with breast cancer stage IV, she is in her 70s and has heart disease, the local hospital is afraid to do surgery, is there any effective treatment?

Combined knife ablation is ultra-fine cold and hot composite ablation, usually within 20-25 minutes of rapid tumor coagulation necrosis, and apoptosis, suitable for advanced elderly patients.

What are the treatment options for recurrent lymphoma?

Diffuse large B cell lymphoma, the effect of this treatment with CAR-T is very good except that it’s expensive. If the your economic condition is good, you can consider using CAR-T treatment, there is hope that you can be ‘cured’!

Esophageal cancer stage IV is poorly treated in local hospitals, is there any other options without removing?

There are many treatments for esophageal cancer, but it’s necessary to confirm whether there are problems such as metastasis. At present, interventional therapy or seed implantation will be more suitable, less painful, and safer.

Get a Free Consultation

Our specialists are ready to review your case and design a personalised treatment plan.
Book Free Consultation
Get Started Today

Ready to Begin Your Treatment Journey?

Our patient coordinators are available 24/7 to review your diagnosis, explain which technologies apply, and arrange a free multidisciplinary case review.
Book a Free Consultation

Prof. Song Shijun

Chief Expert of the Oncology Department
Chief Physician • Professor

Introduction

Prof. Song Shijun is a professor, chief physician, and CPC member with over 40 years of clinical experience in oncology. He specializes in chemotherapy, minimally invasive therapy, biotherapy, and targeted therapy for various solid tumors.

Medical Experience

  • Over 40 years of clinical oncology experience.
  • Chief Expert of the Oncology Department and leader of the Multidisciplinary Team (MDT).
  • Specialized in chemotherapy, minimally invasive therapy, targeted therapy, biotherapy, and integrated cancer treatment.
  • Extensive experience in treating complex and advanced-stage malignant tumors.
  • Pioneer in integrating minimally invasive treatment with immunotherapy and precision medicine.
  • Has successfully treated more than 10,000 cancer patients, with many achieving long-term survival exceeding 10 years.
  • Frequently participates in international oncology conferences and promotes medical collaboration across Southeast Asia.

Research Areas

  • Precision Oncology
  • Minimally Invasive Cancer Therapy
  • Targeted Therapy
  • Biotherapy and Immunotherapy
  • Multidisciplinary Team (MDT) Cancer Management
  • Radiofrequency Ablation (RFA)
  • Palliative Care for Advanced Cancer
  • Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
  • Molecular Biomarkers in Cancer
  • Personalized Cancer Treatment Strategies
Book Consultation

Prof. Dai Wenyan

Director of Oncology Department · Director of Breast Cancer Center
Chief Physician

Introduction

Dr. Ma Xiaoying is a renowned oncologist with over 20 years of clinical experience. Specializing in precision minimally invasive therapy, she has treated more than 5,000 international patients, focusing on improving the quality of life and survival rates for advanced-stage cancer patients.

Medical Experience

  • Over 20 years of clinical work in oncology and cancer research.
  • Expertise in multidisciplinary (MDT) consultation and personalized treatment planning.
  • Completed advanced studies at the National University of Singapore (2015) and Sun Yat-sen University Cancer Center (2017 & 2019).
  • Specialist in minimally invasive techniques including interventional therapy, seed implantation, and cryotherapy.

Research Areas

  • Precision minimally invasive cancer treatment technologies.
  • Combination of targeted therapy, immunotherapy, and chemotherapy for refractory tumors.
  • Endoscopic diagnosis and treatment of malignant tumors.
  • Integrated medical models for advanced-stage cancer management.
Book Consultation

Ma Xiaoying

Director of Oncology Department
Associate Chief Physician

Introduction

Dr. Ma Xiaoying is a renowned oncologist with over 20 years of clinical experience. She specializes in minimally invasive precision treatments, combining targeted therapy and immunotherapy to provide individualized plans for advanced cancer patients, focusing on improving their quality of life.

Medical Experience

  • More than 20 years of extensive clinical work in the field of oncology.
  • Expertise in treating advanced and refractory tumors with rich clinical results.
  • Successfully treated over 5,000 international patients, particularly from Southeast Asia.
  • Proficient in implementing multidisciplinary (MDT) treatment plans and managing cancer complications.

Research Areas

  • Integration of minimally invasive technologies (interventional therapy, cryotherapy, microwave ablation) with molecular targeted therapy.
  • Individualized and comprehensive treatment protocols for solid tumors.
  • Advanced techniques in tumor endoscopy for both diagnosis and treatment.
  • Research on biological immunotherapy and endocrine therapy for late-stage cancers.
Book Consultation

Dr. Wang Baoli

Oncology Specialist
Associate Chief Physician

Introduction

Nearly 20 years of clinical oncology experience in China's top-tier Grade A tertiary hospitals. Expert in minimally invasive interventional therapy, chemotherapy, and combined targeted-immunotherapy, focusing on complex cancers and advocating a Multidisciplinary Team (MDT) treatment approach.

Medical Experience

  • Member, Hepatobiliary and Pancreatic Tumors Professional Committee, Guangzhou Anti-Cancer Association
  • Member, Tumor Immunotherapy Professional Committee, Guangdong Pharmaceutical Association
  • Member, Interventional Medicine Professional Committee, Guangzhou Medical Association
  • Member, Liver Cancer Professional Committee, Tumor Rehabilitation Branch, Chinese Geriatrics Society
  • Member, Thyroid Nodule and Tumor Prevention and Control Professional Committee, China Health Care Association
  • Published 5 papers in core medical journals and 1 SCI-indexed paper
  • Awarded 1 Third Prize for Military Medical Achievements
  • Participated in 1 provincial-level government-funded research project

Research Areas

  • Integrated minimally invasive therapy for tumors
  • Multidisciplinary Team (MDT) precision personalized diagnosis and treatment model
  • Application of combined targeted and immunotherapy strategies in oncology
Book Consultation

FAQ

Introduction

Medical Experience

Research Areas

Book Consultation